All lobbying filings

ASTELLAS PHARMA US, INC.

Lobbying for ASTELLAS PHARMA US, INC.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Illinois · House · Senate · $850,000.00 expenses · posted Oct 20, 2025

Official filing document

Bills named in this filing 2

HR 1300
PSA Screening for HIM Act
S 297
PSA Screening for HIM Act

Lobbying activity 4

Taxation/Internal Revenue Code

Issues related to OBBA (Pub. L. No: 119-21).

Medicare/Medicaid

Issues pertaining to Medicare Part D; H.R. 1300/S. 297 PSA screening bills; Issues related to the Inflation Reduction Act (Pub. L. 117-169); Issues related to OBBA (Pub. L. No: 119-21).

Health Issues

H.R. 1300/S. 297, PSA screening bills; Issues related to Women's Health and Menopause (no specific bills); Issues related to Eye Screening and Access (no specific bills); Issues related to implementation of the Inflation Reduction Act (Pub. L. 117-169); Issues Related to OBBA (Pub. L. No: 119-21); Issues related to health care transparency.

Issues related to IP/Bayh-Dole Act (Pub.L. 96-517).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.